<DOC>
	<DOCNO>NCT01136226</DOCNO>
	<brief_summary>The purpose study determine testosterone recover 90 % year 1 use Eligard .</brief_summary>
	<brief_title>Evaluate Recovery Testosterone Patients Using Eligard</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<criteria>Must outpatient , hospitalize Male Patient age 5080 , inclusive Histologically/Cytologically grade adenocarcinoma prostate Must T1 , T2 T3a adenocarcinoma prostate Must candidate radiation therapy . Hormone refractory patient exclude WHO/ECOG score 0,1 2 NO evidence urinary tract would put patient risk opinion Investigator . Used follow treatment prostate Cancer *immunotherapy *chemotherapy *External Beam Radiation *brachytherapy *hormonal therapy *biological response modifier Prior Prostate Surgery ( exclude TUNA TURP ) Undergone Orchiectomy , adrenalectomy , hypophysectomy receive product could alter function organ Use Investigational Drug , Biologic device within five halflives physiological action three month prior base line , whichever long Over counter alternative medical therapy estrogenic antiandrogenic effect uncontrolled CHF within 6 month baseline Myocardial Infarct , coronary vascular procedure Clinically SignificantCardiovascualr Disease within 6 month baseline Visit Venous thrombosis 6 Months Screening Uncontrolled Hypertension define &gt; 170/100 Symptomatic Hypotension within 3 month Baseline Insulin dependant Diabetic Patients Must administer anatomic region receive Eligard . Drug Alcohol Abuse 6 month prior Baseline Other Serious Illness discretion Investigator Patients receive anticoagulant antiplatlet medication must stable dose 3 month prior Baseline Hypersensitivity GnRH , GnRH agonist</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Prostate Cancer</keyword>
</DOC>